DODGE & COX, a registered investment adviser, initiated a new position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) during Q4 2025, according to its most recent 13F filing…
DODGE & COX, a registered investment adviser, initiated a new position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) during Q4 2025, according to its most recent 13F filing with the Securities and Exchange Commission.
The institutional investor purchased 4,596,358 shares of the Healthcare company, valued at approximately $3.5B as of the filing date.
Regeneron Pharmaceuticals, Inc.'s stock currently trades at $776.66 with a market capitalization of $77.2B.
Current market data
NASDAQ · REGN
$794.19
Down: -$13.52 · -1.67%
Live quote updated
Our Markets Team monitors market data, SEC filings, analyst actions, earnings releases, and corporate announcements to produce timely updates for investors.
Keep reading
price ·
analyst ·
price ·
institutional ·
